Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,042319-   
Low Rs590230-   
Sales per share (Unadj.) Rs298.694.9-  
Earnings per share (Unadj.) Rs35.0-23.9-  
Cash flow per share (Unadj.) Rs49.4-19.8-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.174.5-  
Shares outstanding (eoy) m126.35168.78-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.9 94.4%   
Avg P/E ratio x23.3-11.5 -203.1%  
P/CF ratio (eoy) x16.5-13.9 -119.1%  
Price / Book Value ratio x3.33.7 89.6%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,10846,340 222.5%   
No. of employees `00013.44.3 313.1%   
Total wages/salary Rs m7,8742,908 270.7%   
Avg. sales/employee Rs Th2,807.03,730.7 75.2%   
Avg. wages/employee Rs Th585.8677.5 86.5%   
Avg. net profit/employee Rs Th329.0-940.1 -35.0%   
INCOME DATA
Net Sales Rs m37,73216,016 235.6%  
Other income Rs m577112 514.3%   
Total revenues Rs m38,30916,128 237.5%   
Gross profit Rs m6,901-2,775 -248.6%  
Depreciation Rs m1,824691 263.9%   
Interest Rs m189434 43.5%   
Profit before tax Rs m5,465-3,788 -144.2%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042237 440.4%   
Profit after tax Rs m4,422-4,036 -109.6%  
Gross profit margin %18.3-17.3 -105.5%  
Effective tax rate %19.1-6.2 -305.3%   
Net profit margin %11.7-25.2 -46.5%  
BALANCE SHEET DATA
Current assets Rs m23,77811,730 202.7%   
Current liabilities Rs m10,9756,600 166.3%   
Net working cap to sales %33.932.0 105.9%  
Current ratio x2.21.8 121.9%  
Inventory Days Days104111 93.5%  
Debtors Days Days66124 53.2%  
Net fixed assets Rs m20,3686,838 297.9%   
Share capital Rs m25374 339.8%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,22412,571 248.4%   
Long term debt Rs m1,4094,418 31.9%   
Total assets Rs m45,50723,747 191.6%  
Interest coverage x30.0-7.7 -387.5%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.80.7 122.9%   
Return on assets %10.1-15.2 -66.8%  
Return on equity %14.2-32.1 -44.1%  
Return on capital %17.3-19.8 -87.5%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,9231,367 360.1%  
From Investments Rs m-1,563-420 372.4%  
From Financial Activity Rs m-1,8324,009 -45.7%  
Net Cashflow Rs m1,5284,957 30.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: ABBOTT INDIA  PROCTER & GAMBLE HEALTH  BIOCON   SANOFI INDIA  PANACEA BIOTECH  



Today's Market

Sensex Crashes 667 Points; Banking and Finance Stocks Bleed(Closing)

Indian share markets extended losses as the session progressed and ended their day deep in the red, amid a huge selloff in banking and financial services stocks.

Related Views On News

IPCA LABS Share Price Up by 6%; BSE HEALTHCARE Index Up 1.9% (Market Updates)

Aug 3, 2020 | Updated on Aug 3, 2020

IPCA LABS share price is trading up by 6% and its current market price is Rs 2,033. The BSE HEALTHCARE is up by 1.9%. The top gainers in the BSE HEALTHCARE Index are IPCA LABS (up 5.7%) and LAURUS LABS LTD (up 9.2%). The top losers are DR. LAL PATHLABS LTD (down 0.1%) and NARAYANA HRUDAYALAYA LTD (down 0.6%).

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Why the Stock of HDFC Bank Deserves a Closer Look than Before... (Profit Hunter)

Jul 22, 2020

HDFC Bank's results point to a gaping hole in Indian financial sector. Possibly even a global contagion.

My Best Trading Ideas When Interest Rates Are So Low (Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

The Smallcap Stock that Made Me Change My Asset Allocation Rule (Profit Hunter)

Jul 21, 2020

I believe this smallcap niche leader could deliver a non-linear payoff.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Aug 3, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

FEATURED VIDEOS

MARKET STATS